OptimizeRx to Participate at Investor Conferences in June
2019年5月31日 - 11:30PM
OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital
health messaging for the pharmaceutical industry, has been invited
to participate in two investor conferences being held in June.
Event: William Blair & Company 39th Annual Growth Stock
ConferenceDate: June 5-6, 2019Location: Loews Chicago HotelFormat:
1x1 meetings and presentationPresentation time: 1:20 p.m. Central
time Webcast: click herePlease contact your William Blair
institutional sales representative for registration
information.
Event: Stifel 2019 Cross Sector Insight Conference Date: June
10-12, 2019Location: InterContinental HotelFormat: 1x1 meetings and
presentationPresentation time: 4:10 p.m. Eastern timePlease contact
your Stifel institutional sales representative email for
registration information.
OptimizeRx CEO William Febbo is scheduled to present and
participate in one-on-one meetings with institutional investors and
analysts at both conferences. He will discuss OptimizeRx’s recently
announced first quarter of 2019 results, including how the company
has achieved eight quarters in a row of revenue growth, along with
record gross margin and continued profitability. He will also share
insight on the company’s latest platform integration with the
health care industry’s leading acute EHR
systems that includes Epic and Cerner.
To schedule a one-on-one meeting with OptimizeRx, you may submit
your request via the links provided upon your registration for the
conferences. For any questions about OptimizeRx, please contact Ron
Both of CMA at (949) 432-7557 or submit your request here.
About William BlairWilliam Blair is a premier
global boutique with expertise in investment banking, investment
management, and private wealth management. The company provides
advisory services, strategies, and solutions to meet its clients’
evolving needs. As an independent and employee-owned firm, together
with its strategic partners, William Blair operates in more than 20
offices worldwide. For more information, visit
www.williamblair.com.
About StifelStifel is a full-service investment
firm with a distinguished history of providing securities
brokerage, investment banking, trading, investment advisory, and
related financial services to individual investors, institutions,
corporations, and municipalities. Established in 1890 and
headquartered in St. Louis, Missouri, Stifel is one of the nation’s
leading firms.For more information about Stifel, visit
www.stifel.com.
About OptimizeRxOptimizeRx® (NASDAQ: OPRX), a
digital health company, connects pharmaceutical companies to
patients and providers, offering greater affordability, adherence
and brand awareness at the point-of-care. As the nation’s largest
point-of-prescribe promotional platform for the pharmaceutical
industry, OptimizeRx provides a direct channel for pharma
companies to communicate with healthcare providers right within
their workflow and also directly to patients.
The cloud-based solution supports patient adherence to
medications and better healthcare outcomes with real-time access to
financial assistance, prior authorization, education and critical
clinical information. OptimizeRx provides more than half
of the ambulatory patient market with access to these benefits
through leading EHR platforms like Allscripts, Amazing Charts and
Quest, and directly via its mobile communications
platform.
For more information, follow the company
on Twitter, LinkedIn or
visit www.optimizerx.com.
Important Cautions Regarding Forward Looking
StatementsThis press release contains forward-looking
statements within the definition of Section 27A of the Securities
Act of 1933, as amended, and such as in section 21E of the
Securities Act of 1934, as amended. These forward-looking
statements should not be used to make an investment decision. The
words 'estimate,' 'possible' and 'seeking' and similar expressions
identify forward-looking statements, which speak only as to the
date the statement was made. The company undertakes no obligation
to publicly update or revise any forward-looking statements,
whether because of new information, future events, or otherwise.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted, or quantified.
Future events and actual results could differ materially from those
set forth in, contemplated by, or underlying the forward-looking
statements. The risks and uncertainties to which forward-looking
statements are subject include, but are not limited to, the effect
of government regulation, competition and other material risks.
OptimizeRx ContactDoug Baker, CFOTel (248)
651-6568 x807dbaker@optimizerx.com
Media Relations ContactNicole Brooks, Innsena
CommunicationsTel (860) 800-2344nicolebrooks@innsena.com
Investor Relations ContactRon Both, CMATel
(949) 432-7557oprx@cma.team
OptimizeRx (NASDAQ:OPRX)
過去 株価チャート
から 6 2024 まで 7 2024
OptimizeRx (NASDAQ:OPRX)
過去 株価チャート
から 7 2023 まで 7 2024